Clinical Trial Update: Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating lenalidomide in older adults with acute myeloid leukemia has been completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2013-07-04